L'IMPERIO, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 8.905
AS - Asia 7.786
EU - Europa 6.103
SA - Sud America 1.169
AF - Africa 134
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 4
Totale 24.120
Nazione #
US - Stati Uniti d'America 8.637
SG - Singapore 3.132
IT - Italia 2.010
CN - Cina 1.691
VN - Vietnam 1.154
RU - Federazione Russa 988
HK - Hong Kong 984
BR - Brasile 939
DE - Germania 782
SE - Svezia 623
IE - Irlanda 470
GB - Regno Unito 245
KR - Corea 171
AT - Austria 160
FR - Francia 159
CA - Canada 151
ID - Indonesia 137
IN - India 135
FI - Finlandia 122
UA - Ucraina 113
NL - Olanda 112
AR - Argentina 88
MX - Messico 85
TR - Turchia 71
DK - Danimarca 67
PL - Polonia 65
BD - Bangladesh 59
ZA - Sudafrica 58
JP - Giappone 55
IQ - Iraq 43
EC - Ecuador 35
ES - Italia 35
PK - Pakistan 32
BE - Belgio 26
LT - Lituania 26
CO - Colombia 23
CH - Svizzera 18
SA - Arabia Saudita 18
UY - Uruguay 18
AU - Australia 17
MA - Marocco 17
PY - Paraguay 17
VE - Venezuela 17
PE - Perù 16
AE - Emirati Arabi Uniti 15
GR - Grecia 15
TN - Tunisia 14
PT - Portogallo 13
CL - Cile 12
EG - Egitto 9
UZ - Uzbekistan 9
CZ - Repubblica Ceca 8
JO - Giordania 8
PH - Filippine 8
AL - Albania 7
AZ - Azerbaigian 7
DO - Repubblica Dominicana 7
KE - Kenya 7
CR - Costa Rica 6
DZ - Algeria 6
IL - Israele 6
LV - Lettonia 6
PA - Panama 6
RS - Serbia 6
BG - Bulgaria 5
HU - Ungheria 5
IR - Iran 5
JM - Giamaica 5
LB - Libano 5
TH - Thailandia 5
BO - Bolivia 4
BY - Bielorussia 4
KZ - Kazakistan 4
MY - Malesia 4
NO - Norvegia 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
AM - Armenia 3
AO - Angola 3
GA - Gabon 3
GE - Georgia 3
OM - Oman 3
SC - Seychelles 3
TW - Taiwan 3
BH - Bahrain 2
ET - Etiopia 2
EU - Europa 2
HN - Honduras 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LY - Libia 2
MU - Mauritius 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BN - Brunei Darussalam 1
BT - Bhutan 1
Totale 24.106
Città #
Singapore 1.770
Ann Arbor 1.477
Ashburn 1.091
Hong Kong 975
Milan 599
Frankfurt am Main 476
Dublin 452
Dallas 417
Hefei 411
Fairfield 386
Ho Chi Minh City 366
Chandler 346
Santa Clara 317
New York 315
Wilmington 291
Los Angeles 289
Hanoi 280
Beijing 248
Houston 225
Woodbridge 219
Seattle 163
Seoul 157
Princeton 134
Dearborn 133
Buffalo 122
Cambridge 114
Jakarta 106
São Paulo 105
Shanghai 102
Vienna 102
Moscow 94
The Dalles 87
Munich 82
Jacksonville 81
Chicago 76
London 65
Nanjing 60
Rome 60
Warsaw 57
Helsinki 56
Dong Ket 54
Kent 53
Altamura 52
Denver 50
Lawrence 50
Nuremberg 49
Guangzhou 46
Montreal 44
Da Nang 43
Tokyo 43
Toronto 40
Florence 38
Johannesburg 34
Monza 34
Orem 34
Stockholm 34
Chennai 33
Boardman 32
Hải Dương 32
Phoenix 32
Poplar 31
Salt Lake City 31
Mexico City 30
Lissone 29
Haiphong 28
Atlanta 27
Council Bluffs 27
Ha Long 27
Turku 27
Lappeenranta 26
Naples 26
Rio de Janeiro 26
Brooklyn 25
Nanchang 24
Pune 24
Amsterdam 23
Brussels 23
Istanbul 23
San Diego 23
Boston 22
Cinisello Balsamo 22
Turin 22
Bologna 21
Manchester 20
Ankara 19
Biên Hòa 19
Changsha 19
Shenyang 19
Zhengzhou 19
Falls Church 18
Thái Nguyên 18
Tianjin 18
Düsseldorf 17
Ottawa 17
Quận Bình Thạnh 17
Sesto San Giovanni 17
Andover 16
Bari 16
Ninh Bình 16
Quito 16
Totale 14.621
Nome #
The putative role of MALDI-MSI in the study of Membranous Nephropathy 384
Rendering the invisible visible: adding a molecular dimension to pathology with spatial omics 348
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 348
MALDI imaging in Fabry nephropathy: a multicenter study 346
The proteomic landscape of renal tumors 340
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 340
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 331
Analysis of Hashimoto's thyroiditis on fine needle aspiration samples by MALDI-Imaging 322
Kidney Involvement 319
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 314
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 307
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 306
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 302
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 288
Cytopathology of Bronchoalveolar Lavages in COVID-19 Pneumonia: A Pilot Study 283
Proteomics for the study of new biomarkers in Fabry disease: State of the art 282
Sequential MALDI-HiPLEX-IHC and Untargeted Spatial Proteomics Mass Spectrometry Imaging to Detect Proteomic Alterations Associated with Tumour Infiltrating Lymphocytes 277
"Pathologists in Venice - Real World Cases for an Immersive Training Experience": Education, Gaming, and Show 271
Proteome analysis in thyroid pathology 267
PD-L1 Testing and Squamous Cell Carcinoma of the Head and Neck: A Multicenter Study on the Diagnostic Reproducibility of Different Protocols 264
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 260
Benchmarking digital displays (monitors) for histological diagnoses: the nephropathology use case 257
Granulomatosis with polyangiitis presenting with diffuse alveolar hemorrhage requiring extracorporeal membrane oxygenation with rapid multiorgan relapse: A case report 255
Digital counting of tissue cells for molecular analysis: the QuANTUM pipeline 246
Cytomolecular Classification of Thyroid Nodules Using Fine-Needle Washes Aspiration Biopsies 243
Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis 240
Debating the pros and cons of computational pathology at the European Congress of Pathology (ECP) 2024 238
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 238
Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patient 237
Machine learning streamlines the morphometric characterization and multi-class segmentation of nuclei in different follicular thyroid lesions: everything in a NUTSHELL 229
Diagnostic performances of the acr-tirads system in thyroid nodules triage: A prospective single center study 227
Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity 224
Immunosuppression in idiopathic membranous nephropathy: A double-edge sword 222
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 221
Nodal monoclonal CD5-positive B-lymphocytosis and toxoplasma lymphadenitis: Another variant in the spectrum of infectious lymphadenitis in patients with chronic leukemia/small lymphocytic lymphoma 220
Use of diagnostic criteria from acr and eu-tirads systems to improve the performance of cytology in thyroid nodule triage 213
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs) 212
Lipids, proteins, cells: advanced spatial multiomics to delve deeper into the complex molecular and cellular landscape of the tumour microenvironment 208
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 207
Digital transition in pathology lab: a survey from the Lombardy region 200
Dissecting the histological features of lupus nephritis highlights new common patterns of injury in class III/IV 198
Displaced Cartilage Within Lymph Node Parenchyma Is a Novel Biopsy Site Change in Resected Mediastinal Lymph Nodes Following EBUS-TBNA 197
More than an ‘atypical’ phenotype: dual molecular diagnosis of autoimmune lymphoproliferative syndrome and Becker muscular dystrophy 196
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 191
Improvements in digital pathology equipment for renal biopsies: updating the standard model 189
MALDI-MS imaging in the study of glomerulonephritis 189
Monoclonal gammopathy of renal significance: Systemic involvement by benign condition 186
The Complex Cyto-Molecular Landscape of Thyroid Nodules in Pediatrics 184
Destructuring glomerular diseases with structured deposits: challenges in the precision medicine era 184
Anticoagulant-related nephropathy: a pathological note 182
The therapeutic potential of an allosteric non-competitive CXCR1/2 antagonist for diabetic nephropathy 180
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome 174
Goodpasture syndrome and anti-glomerular basement membrane disease 173
The routine use of a digital tool for the tumor cell fraction quantification in molecular pathology: an international validation of QuANTUM 172
Improving the Annotation Process in Computational Pathology: A Pilot Study with Manual and Semi-automated Approaches on Consumer and Medical Grade Devices 171
Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis 170
The role of digital and integrative pathology for the detection of translocations: a narrative review 170
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 170
A Mass Spectrometry Imaging-based multiomics approach to map the tumour-immune landscape of clear cell Renal Cell Carcinoma and gain insights into resistance to immunotherapy 169
Tumour incidence in Fabry disease: A cross-sectional study 168
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 167
Monoclonal Gammopathy of Renal Significance: A Molecular Middle Earth between Oncology, Nephrology, and Pathology 165
An Indeterminate for Malignancy FNA Report Does Not Increase the Surgical Risk of Incidental Thyroid Carcinoma 165
Kidney Function, CKD Causes, and Histological Classification 165
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 164
The putative role of MALDI-MSI in the study of Membranous Nephropathy 162
Economic assessment of NGS testing workflow for NSCLC in a healthcare setting 161
Different clusters in patients with lupus podocytopathy identified by clinical-pathological characteristics 160
The putative role of MALDI-MSI in the study of Membranous Nephropathy 160
Digital pathology for the routine diagnosis of renal diseases: a standard model 159
Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitis 155
#EBUSTwitter: Novel use of social media for conception, coordination, and completion of an international, multicenter pathology study 154
Pathologist Validation of a Machine Learning-Derived Feature for Colon Cancer Risk Stratification 152
Artificial intelligence–based algorithms for the diagnosis of prostate cancer: A systematic review 152
Pathology Laboratory Archives: Conservation Quality of Nucleic Acids and Proteins for NSCLC Molecular Testing 152
Liquid-based shaking of core needle biopsy samples for the molecular characterization of tumors: A fallback in cytopathology 152
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 151
Autopsia di Innocenzo XII. Un’attestazione dell’utilizzo del microscopio in ambito necroscopico nel XVII secolo 148
Enhancing proteomics characterization of thyroid nodules: a pixel-classifier for mass spectrometry imaging analyses 147
Digital twin manifesto for the pathology laboratory 147
Un nuovo approccio basato sull’Imaging con Spettrometria di Massa per la sottotipizzazione dell’amiloidosi renale [A novel mass spectrometry imaging based approach for the subtyping of renal amyloidosisn] 145
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 144
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 142
6-Aza-2-Thiothymine as an Alternative Matrix for Spatial Proteomics with MALDI-MSI 141
The Puzzle of Preimplantation Kidney Biopsy Decision-Making Process: The Pathologist Perspective 140
Renal involvement in eosinophilic granulomatosis with polyangiitis 140
JAK2-mutated Langerhans cell histiocytosis associated with primary myelofibrosis treated with ruxolitinib 139
Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions 138
Response to: 'Correspondence on 'Bowman's capsule rupture on renal biopsy improves the outcome prediction of ANCA-associated glomerulonephritis classifications'' by Hakroush and Tampe 138
Imaging molecolare a livello cellulare: possiamo predire la risposta alla terapia nella Nefropatia Membranosa? 137
High spatial resolution MALDI-MSI in the search for proteomic indicators of response to therapy in Membranous Nephropathy 137
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 136
MALDI-MS Imaging in Membranous Nephropathy: from the research to the clinical laboratory? 135
Delving deeper into the Tumour Microenvironment: a MS-driven spatial multiomics approach to provide new molecular insights into immune-tumour cell communication 134
Automate the process of formalin-fixed paraffin-embedded blocks storage in the pathology laboratory: A proof of concept study 133
Changing Phenotypes and Clinical Outcomes Over Time in Microscopic Polyangiitis 133
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology 131
Cost analysis of archives in the pathology laboratories: from safety to management 130
Systemic vasculitis involving the kidney: the nephropathologist's point of view 127
The evolving landscape of anatomic pathology 126
Totale 20.313
Categoria #
all - tutte 83.363
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.363


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.128 0 0 0 0 0 170 166 198 148 159 120 167
2021/20221.189 145 131 127 68 68 101 26 79 33 83 123 205
2022/20231.928 185 503 193 146 106 275 53 144 164 41 81 37
2023/20241.950 67 85 86 121 190 442 351 70 175 40 87 236
2024/20256.832 234 517 624 277 469 287 329 219 645 1.000 884 1.347
2025/20268.845 1.962 1.303 1.414 2.009 1.864 293 0 0 0 0 0 0
Totale 24.784